Neogen (NEOG) Stock
Food safety testing and veterinary diagnostics provider. Here's the price, business snapshot, and what's worth knowing about Neogen in October 2026.
Neogen Corporation (NEOG) supplies testing, products and services aimed at food and animal safety. The company sells diagnostic kits, sanitising and lab equipment, veterinary instruments and related consumables to food processors, retailers and animal-health customers. With a market capitalisation around $1.28bn, Neogen operates in a specialist niche where regulatory standards, outbreak prevention and quality assurance drive demand. Growth has come from product development and selective acquisitions, giving scale in both testing technologies and consumables. Investors should note the business can be cyclical with exposure to food-industry spending and margins influenced by raw‑material and integration costs. This summary is general educational information, not personalised advice — stocks can fall as well as rise, and suitability depends on your financial situation and risk tolerance.
Neogen (NEOG) Stock Forecast
Analyst price target, next 12 months
$14.33
+17.6% vs today's $12.19
Price range over the last 12 months
In the middle of its 12-month range
Analysts covering Neogen have a consensus 12-month target of $14.33, above the current price of $12.19.
Analyst targets are opinions, not guarantees. Capital at risk. Data as of 25 Oct 2026.
Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.
Sixth Month Growth Performance
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying NEOGEN's stock with a target price of $14.33, indicating growth potential.
Financial Health
Neogen Corp shows strong revenue and profit generation, indicating solid financial performance.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Why You’ll Want to Watch This Stock
Recurring Consumables Demand
A sizeable portion of sales are repeat consumables and reagents, which can provide revenue durability — though volumes may vary with industry spending.
Regulation Supports Need
Tighter food‑safety rules and globalisation of supply chains can increase demand for testing and traceability, yet regulatory shifts can also change buyer behaviour.
Product & Acquisition Strategy
Neogen grows through new diagnostics and selective acquisitions that expand capabilities and distribution, but integration and margin effects warrant attention.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
